What are the different types of cardiorenal syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiorenal Syndrome Classification

Cardiorenal syndrome is classified into five distinct types based on the primary organ dysfunction (heart versus kidney) and the temporal course (acute versus chronic), with Types 1-4 representing unidirectional organ injury and Type 5 representing systemic disease affecting both organs simultaneously. 1

The Five Types of CRS

Type 1: Acute Cardiorenal Syndrome

  • Acute heart failure causes acute kidney injury (AKI), most commonly encountered in patients with pre-existing heart conditions 2, 1
  • Characterized by abrupt worsening of cardiac function (e.g., acute cardiogenic shock or decompensated congestive heart failure) leading to AKI 3, 4
  • This is the most frequently seen subtype in coronary care units and cardiothoracic intensive care units 4

Type 2: Chronic Cardiorenal Syndrome

  • Chronic heart failure causes chronic kidney disease (CKD), characterized by chronic renal hypoperfusion and sustained neurohormonal activation 2, 1
  • Describes chronic abnormalities in cardiac function (e.g., chronic congestive heart failure) causing progressive and permanent chronic kidney disease 3
  • Long-term activation of the renin-angiotensin-aldosterone (RAA) system creates a vicious cycle of deterioration in this type 1

Type 3: Acute Renocardiac Syndrome

  • AKI or acute renal failure causes acute cardiac failure, leading to cardiac injury and/or dysfunction 2, 1
  • Consists of abrupt worsening of renal function (e.g., acute kidney ischemia or glomerulonephritis) causing acute cardiac disorders such as heart failure, arrhythmia, or ischemia 3, 4
  • This subtype is of particular interest to critical care specialists 4

Type 4: Chronic Renocardiac Syndrome

  • CKD causes chronic cardiac dysfunction, including heart failure, with left ventricular hypertrophy and diastolic dysfunction as common cardiac manifestations 2, 1
  • Describes a state of chronic kidney disease (e.g., chronic glomerular disease) contributing to decreased cardiac function, cardiac hypertrophy, and/or increased risk of adverse cardiovascular events 3

Type 5: Secondary Cardiorenal Syndrome

  • Systemic conditions cause both cardiac and renal dysfunction simultaneously 1
  • Reflects systemic conditions (e.g., diabetes mellitus, sepsis) causing both cardiac and renal dysfunction 3, 5
  • This type represents concurrent, chronic cardiac and renal failure from a common systemic etiology 6

Clinical Significance of Classification

  • The classification reflects the presumed primary and secondary problem, which is critical for directing management strategies 1
  • Types 1 and 2 are particularly relevant when managing heart failure medications, as drugs like loop diuretics can worsen renal function through hypovolemia and reduced renal perfusion 1
  • The bidirectional link between cardiac and renal function means that up to a quarter of patients with CKD have symptoms suggestive of heart failure before a formal diagnosis is made 2

Pathophysiological Mechanisms

  • Decreased cardiac output leads to reduced renal perfusion, a key mechanism in Types 1 and 2 1
  • Venous congestion is transmitted to the renal vasculature, causing chronic renal venous congestion, which reduces glomerular blood flow by reducing the pressure gradient between afferent and efferent arterioles 2
  • Right ventricular dilation in heart failure increases central venous pressure (CVP), which lowers cardiac output and decreases renal perfusion 2

Common Pitfalls

  • Overdiuresis can worsen renal perfusion and activate the RAA system, creating a vicious cycle 1
  • Discontinuing beneficial heart failure medications prematurely due to mild changes in renal function is a common error 1
  • Modest increases in creatinine during effective decongestion therapy may not necessarily indicate worse outcomes 1

References

Guideline

Cardiorenal Syndrome: Definition, Pathophysiology, and Clinical Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiorenal syndromes: definition and classification.

Contributions to nephrology, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.